Wüsten werden häufig mit Hitze, Trockenheit und lebensfeindlichen Bedingungen verbunden. Dabei sind sie keineswegs einfach nur „leere“ Landschaften. Sie sind dynamische Lebensräume, die durch geologis...

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with thousands of subscribers.

YouTube video by Triple-Q

Valion Bio (Nasdaq: VBIO) announced a 1-for-25 reverse stock split of its issued and outstanding common shares, effective August 31, 2026, at 12:01 a.m. Eastern Time. VBIO is expected to begin trading on a split-adjusted basis that same day under its existing ticker, with a new CUSIP of 918942202.The split, approved by stockholders on August 14, 2026, is intended to help Valion Bio regain compliance with Nasdaq’s minimum $1.00 bid price requirement before the current September 15, 2026 deadline. All 25 pre-split shares will be reclassified into one share, with proportional adjustments to preferred stock conversion terms, equity awards, options, warrants and equity plan reserves. No fractional shares will be issued; any fraction will be rounded up to the nearest whole share. The number of authorized shares, par value, and outstanding preferred stock will remain unchanged, and Odyssey Transfer and Trust Company will act as exchange agent.

Descriptive, non-directional summary of recent AI analyses.